PTEN Status Predicts Prostate Cancer Outcomes as Well as Multigene Panel PTEN Status Predicts Prostate Cancer Outcomes as Well as Multigene Panel

PTEN loss by tumor immunohistochemistry (IHC) predicts prostate-cancer outcomes after radical prostatectomy as well as a commercial multigene panel does.Reuters Health Information (Source: Medscape Allergy Headlines)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2yiFMK2